The difference in response to TAVO412 could be explained by the different levels of EGFR receptor expression in these cell lines, considering the fact that Fc-dependent activity plays a critical role in tumor inhibition efficacy in vivo while the effector functions were driven by the anti-EGFR arm of TAVO412. Here, EGFR is linked to neoplasm.